Similar articles for PMID: 18498363

Year	Number of Results
1998	1
2005	1
2006	2
2007	10
2008	7
2009	2
2010	1
2011	1
2017	1
2018	2
2019	1
2022	1
2024	0

1

PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans.

Dewpura T, Raymond A, Hamelin J, Seidah NG, Mbikay M, Chrétien M, Mayne J. Dewpura T, et al. FEBS J. 2008 Jul;275(13):3480-93. doi: 10.1111/j.1742-4658.2008.06495.x. Epub 2008 May 22. FEBS J. 2008. PMID: 18498363 Free article.

2

The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.

Nassoury N, Blasiole DA, Tebon Oler A, Benjannet S, Hamelin J, Poupon V, McPherson PS, Attie AD, Prat A, Seidah NG. Nassoury N, et al. Traffic. 2007 Jun;8(6):718-32. doi: 10.1111/j.1600-0854.2007.00562.x. Epub 2007 Apr 25. Traffic. 2007. PMID: 17461796 Free article.

3

Cellular and secreted pro-protein convertase subtilisin/kexin type 9 catalytic activity in hepatocytes.

Kourimate S, Chétiveaux M, Jarnoux AL, Lalanne F, Costet P. Kourimate S, et al. Atherosclerosis. 2009 Sep;206(1):134-40. doi: 10.1016/j.atherosclerosis.2009.02.012. Epub 2009 Feb 20. Atherosclerosis. 2009. PMID: 19269636

4

Binding to the low-density lipoprotein receptor accelerates futile catalytic cycling in PCSK9 and raises the equilibrium level of intramolecular acylenzyme.

Geoghegan KF, Hoth LR, Varghese AH, Lin W, Boyd JG, Griffor MC. Geoghegan KF, et al. Biochemistry. 2009 Apr 7;48(13):2941-9. doi: 10.1021/bi802232m. Biochemistry. 2009. PMID: 19222187

5

Plasma PCSK9 levels correlate with cholesterol in men but not in women.

Mayne J, Raymond A, Chaplin A, Cousins M, Kaefer N, Gyamera-Acheampong C, Seidah NG, Mbikay M, Chrétien M, Ooi TC. Mayne J, et al. Biochem Biophys Res Commun. 2007 Sep 21;361(2):451-6. doi: 10.1016/j.bbrc.2007.07.029. Epub 2007 Jul 18. Biochem Biophys Res Commun. 2007. PMID: 17645871

6

Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia.

Cunningham D, Danley DE, Geoghegan KF, Griffor MC, Hawkins JL, Subashi TA, Varghese AH, Ammirati MJ, Culp JS, Hoth LR, Mansour MN, McGrath KM, Seddon AP, Shenolikar S, Stutzman-Engwall KJ, Warren LC, Xia D, Qiu X. Cunningham D, et al. Nat Struct Mol Biol. 2007 May;14(5):413-9. doi: 10.1038/nsmb1235. Epub 2007 Apr 15. Nat Struct Mol Biol. 2007. PMID: 17435765

7

Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system.

Poirier S, Prat A, Marcinkiewicz E, Paquin J, Chitramuthu BP, Baranowski D, Cadieux B, Bennett HP, Seidah NG. Poirier S, et al. J Neurochem. 2006 Aug;98(3):838-50. doi: 10.1111/j.1471-4159.2006.03928.x. J Neurochem. 2006. PMID: 16893422 Free article.

8

Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion.

Cameron J, Holla ØL, Berge KE, Kulseth MA, Ranheim T, Leren TP, Laerdahl JK. Cameron J, et al. FEBS J. 2008 Aug;275(16):4121-33. doi: 10.1111/j.1742-4658.2008.06553.x. Epub 2008 Jul 9. FEBS J. 2008. PMID: 18631360 Free article.

9

Inhibition of PCSK9 as a novel strategy for the treatment of hypercholesterolemia.

Lopez D. Lopez D. Drug News Perspect. 2008 Jul-Aug;21(6):323-30. doi: 10.1358/dnp.2008.21.6.1246795. Drug News Perspect. 2008. PMID: 18836590 Free article. Review.

10

Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.

Lambert G, Jarnoux AL, Pineau T, Pape O, Chetiveaux M, Laboisse C, Krempf M, Costet P. Lambert G, et al. Endocrinology. 2006 Oct;147(10):4985-95. doi: 10.1210/en.2006-0098. Epub 2006 Jun 22. Endocrinology. 2006. PMID: 16794006

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

30 results

Results by year